Rituximab Patent Expiration
Rituximab Large Molecule Patents
Given below is the list of large molecule patents protecting Rituximab, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Rituxan | USUS10450379 | Method for treating joint damage | Nov 14, 2026 | Genentech, Inc. |
| Rituxan | USUS10654940 | Method for treating joint damage | Nov 14, 2026 | Genentech, Inc. |
| Rituxan | USUS10759866 | Prevention of disulfide bond reduction during recombinant production of polypeptides | Jul 08, 2028 | Genentech, Inc. |
| Rituxan | USUS7976838 | Therapy of autoimmune disease in a patient with an inadequate response to a TNF-α inhibitor | Jun 30, 2025 | Genentech, Inc. |
Rituximab's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List